Tocilizumab: A novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases

By Alten Rieke   Maleitzke Tazio  

Annals of Medicine, Vol. 45, Iss. 4, 2013-06 ,pp. : 357-363

Informa Healthcare

Access to resources Recommend Favorite

Modulation of VIPergic phenotype of enteric neurons by colonic biopsy supernatants from patients with inflammatory bowel diseases: Involvement of IL‐6 in Crohn's disease

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 30, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti-Interleukin-6 Receptor Antibody Treatment in Inflammatory Autoimmune Diseases

By  

Reviews on Recent Clinical Trials, Vol. 1, Iss. 3, 2006-09 ,pp. : 193-200

Bentham Science Publishers

Access to resources Recommend Favorite

New strategies for the treatment of inflammatory bowel diseases

By Roblin Xavier   Dronne William   Paul Stéphane   Tedesco Emilie Del  

Clinical Investigation, Vol. 3, Iss. 5, 2013-05 ,pp. : 479-492

Future Science

Access to resources Recommend Favorite

Anti-inflammatory response of IL-4, IL-10 and TGF-β in patients with systemic inflammatory response syndrome

By Torre Donato   Tambini Roberto   Aristodemo Silvana   Gavazzeni Giovanna   Goglio Antonio   Cantamessa Carla   Pugliese Agostino   Biondi Gilberto  

Mediators of Inflammation, Vol. 9, Iss. 3-4, 2000-08 ,pp. : 193-195

Informa Healthcare

Access to resources Recommend Favorite